GLOMERULAR FUNCTION AND STRUCTURE IN THE SODIUM-REPLETE AND SODIUM-DEPLETE UNINEPHRECTOMIZED SPONTANEOUSLY HYPERTENSIVE RAT - EFFECT OF BLOOD-PRESSURE REDUCTION, GLOMERULAR STRUCTURE, AND BLOOD-PRESSURE REDUCTION
G. Reams et al., GLOMERULAR FUNCTION AND STRUCTURE IN THE SODIUM-REPLETE AND SODIUM-DEPLETE UNINEPHRECTOMIZED SPONTANEOUSLY HYPERTENSIVE RAT - EFFECT OF BLOOD-PRESSURE REDUCTION, GLOMERULAR STRUCTURE, AND BLOOD-PRESSURE REDUCTION, The American journal of the medical sciences, 309(1), 1995, pp. 35-42
To assess the effects of chronic dietary sodium restriction and blood
pressure reduction on glomerular function and structure during the pat
hogenesis of hypertensive renal disease, experiments were conducted in
uninephrectomized (UNX) spontaneously hypertensive rats (SHR) using t
he dihydropyridine calcium antagonist manidipine. Male SHRs underwent
UNX at age 10-11 weeks and subsequently were assigned to one of four g
roups: sodium-replete (0.4%); sodium-replete and a predetermined antih
ypertensive dose of manidipine (20 mg/kg body weight); sodium-deplete
(0.09%); and sodium-deplete and manidipine (20 mg/kg body weight). Twe
lve weeks later, renal morphologic and functional studies were perform
ed. Sodium restriction had no significant effect on systolic blood pre
ssure, but creatinine clearance and urinary protein excretion were dec
reased, Importantly, mean glomerular volume and the prevalence of mesa
ngial expansion were lower with sodium restriction. This occurred in t
he presence of high concentrations of plasma and renal tissue angioten
sin II. Manidipine significantly reduced systolic blood pressure in th
e sodium-replete and sodium-deplete UNX-SHRs. This therapy was not ass
ociated with significant changes in creatinine clearance and urinary p
rotein excretion in the sodium-deplete or sodium-replete UNX-SHRs. The
prevalence of mesangial expansion in the sodium-replete UNX-SHR was a
pproximately 50% lower with manidipine. Plasma and renal tissue angiot
ensin II concentrations were not affected by the drug. In the sodium-d
eplete UNX-SHR, the prevalence of mesangial expansion was not reduced
further by manidipine. However, plasma and renal tissue angiotensin II
concentrations were increased significantly. Based on the results of
this study, 1) in the sodium-replete UNX-SHR, the calcium antagonist m
anidipine, given as effective antihypertensive therapy, attenuates ear
ly glomerular injury without altering circulating or renal tissue angi
otensin II; 2) sodium depletion, independent of blood pressure and sti
mulation of circulating and renal tissue angiotensin II, attenuates ea
rly glomerular injury after uninephrectomy; and 3) in sodium-deplete U
NX-SHR, effective antihypertensive treatment with manidipine does not
produce an additional reduction in early glomerular injury.